Miller Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Sell |
181,536
-8,098
| -4% | -$712K | 1.68% | 15 |
|
|
2025
Q1 | $17.3M | Sell |
189,634
-380
| -0.2% | -$34.6K | 1.91% | 12 |
|
|
2024
Q4 | $16.4M | Sell |
190,014
-17,521
| -8% | -$1.51M | 1.79% | 13 |
|
|
2024
Q3 | $19.7M | Buy |
207,535
+24,446
| +13% | +$2.32M | 2.05% | 10 |
|
|
2024
Q2 | $16.7M | Buy |
183,089
+39,044
| +27% | +$3.57M | 2% | 14 |
|
|
2024
Q1 | $13.1M | Buy |
144,045
+1,036
| +0.7% | +$94K | 1.67% | 19 |
|
|
2023
Q4 | $11.6M | Sell |
143,009
-1,410
| -1% | -$115K | 1.66% | 20 |
|
|
2023
Q3 | $11.5M | Sell |
144,419
-564
| -0.4% | -$45K | 1.82% | 16 |
|
|
2023
Q2 | $11.4M | Buy |
144,983
+141,793
| +4,445% | +$11.2M | 1.74% | 17 |
|
|
2023
Q1 | $248K | Buy |
3,190
+267
| +9% | +$20.7K | 0.04% | 87 |
|
|
2022
Q4 | $227K | Buy |
+2,923
| New | +$227K | 0.04% | 89 |
|